Immunology Biomarkers, Janssen Research & Development, USA
Dr Liu joins the company after an extensive career in academia, which most recently saw him serve as VP and chief scientific officer at the Baylor Research Institute and director of the Baylor Institute for Immunology Research.He also served for a period as chair of the Department of Immunology at the University of Texas.MedImmune focuses on the development of biologics and will look to benefit from Dr Liu's experience in immunology as it works to develop a portfolio of immunotherapies, including investigational cancer treatments.
Biomarker
Nephrotoxicity
Glomerulus
Doxorubicin
Cardiovascular Diseases & Diagnosis received 427 citations as per Google Scholar report